Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Rapid Dose Therapeutics Corp has secured an additional Mitacs Accelerate grant to advance their QuickStrip™ Oral Thin Film technology for vaccine delivery, eliminating the need for intramuscular injections and cold-chain storage. The ongoing research partnership with McMaster University, supported by a total of $85,000 in grants, is set to revolutionize vaccination methods by enabling buccal or sublingual administration. CEO Mark Upsdell highlights the potential for QuickStrip™ to address healthcare delivery and environmental challenges, particularly in regions where traditional vaccine logistics are problematic.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.
